The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma
Open accessAbstract
Hepatocellular carcinoma (HCC) is mainly associated with chronic hepatitis B virus (HBV) and/or hepatitis C virus (HCV) infections. This Review outlines pathogenic mechanisms that seem to be common to both HBV and HCV, in the hope that this might suggest innovative approaches for the prevention and treatment of HCC. Hepatocellular carcinoma (HCC) is a highly lethal cancer, with increasing worldwide incidence, that is mainly associated with chronic hepatitis B virus (HBV) and/or hepatitis C virus (HCV) infections. There are few effective treatments partly because the cell- and molecular-based mechanisms that contribute to the pathogenesis of this tumour type are poorly understood. This Review outlines pathogenic mechanisms that seem to be common to both viruses and which suggest innovative approaches to the prevention and treatment of HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Ge, D., Fellay, J., Thompson, A. J., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H., Muir, A. J., et al. (2009) · Nature · doi:10.1038/nature08309 · Cited by 3,514
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047
Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
Yang, J., & Weinberg, R. A. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.05.009 · Cited by 3,012
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
Beasley, R. P., Lin, C.-C., Hwang, L.-Y., & Chien, C.-S. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90585-7 · Cited by 2,865
TGF-β-induced epithelial to mesenchymal transition
Xu, J., Lamouille, S., & Derynck, R. (2009) · Cell Research · doi:10.1038/cr.2009.5 · Cited by 2,804
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
Fattovich, G., Stroffolini, T., Zagni, I., & Donato, F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.014 · Cited by 2,591
Lee, W. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712113372406 · Cited by 2,569
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
Thomas, D. L., Thio, C. L., Martin, M. P., Qi, Y., Ge, D., O’hUigin, C., Kidd, J., Kidd, K., Khakoo, S. I., Alexander, G., et al. (2009) · Nature · doi:10.1038/nature08463 · Cited by 2,150
Autophagy Is Activated for Cell Survival after Endoplasmic ReticulumStress
Ogata, M., Hino, S.-I., Saito, A., Morikawa, K., Kondo, S., Kanemoto, S., Murakami, T., Taniguchi, M., Tanii, I., Yoshinaga, K., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01453-06 · Cited by 1,832
Diagnosis, management, and treatment of hepatitis C†
Strader, D. B., Wright, T., Thomas, D. L., & Seeff, L. B. (2004) · Hepatology · doi:10.1002/hep.20119 · Cited by 1,709
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
Baylin, S. B., & Ohm, J. E. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1799 · Cited by 1,639
Immunology of hepatitis B virus and hepatitis C virus infection
Rehermann, B., & Nascimbeni, M. (2005) · Nature Reviews Immunology · doi:10.1038/nri1573 · Cited by 1,627
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
Kang, T.-W., Yevsa, T., Woller, N., Hoenicke, L., Wuestefeld, T., Dauch, D., Hohmeyer, A., Gereke, M., Rudalska, R., Potapova, A., et al. (2011) · Nature · doi:10.1038/nature10599 · Cited by 1,621
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482
The Snail genes as inducers of cell movement and survival: implications in development and cancer
Barrallo-Gimeno, A., & Nieto, M. A. (2005) · Development · doi:10.1242/dev.01907 · Cited by 1,394
Tiollais, P., Pourcel, C., & Dejean, A. (1985) · Nature · doi:10.1038/317489a0 · Cited by 1,205
Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection
Thimme, R., Oldach, D., Chang, K.-M., Steiger, C., Ray, S. C., & Chisari, F. V. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.10.1395 · Cited by 1,189
Hypoxia-Inducible Factors, Stem Cells, and Cancer
Keith, B., & Simon, M. C. (2007) · Cell · doi:10.1016/j.cell.2007.04.019 · Cited by 1,179
Yamashita, T., Ji, J., Budhu, A., Forgues, M., Yang, W., Wang, H., Jia, H., Ye, Q., Qin, L., Wauthier, E., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.004 · Cited by 1,149
Sells, M. A., Chen, M. L., & Acs, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.4.1005 · Cited by 1,117
Li, K., Foy, E., Ferreon, J. C., Nakamura, M., Ferreon, A. C. M., Ikeda, M., Ray, S. C., Gale, M., & Lemon, S. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408824102 · Cited by 1,092
Intracellular Inactivation of the Hepatitis B Virus by Cytotoxic T Lymphocytes
Guidotti, L. G., Ishikawa, T., Hobbs, M. V., Matzke, B., Schreiber, R., & Chisari, F. V. (1996) · Immunity · doi:10.1016/s1074-7613(00)80295-2 · Cited by 1,083
Molecular targeted therapies in hepatocellular carcinoma†
Llovet, J. M., & Bruix, J. (2008) · Hepatology · doi:10.1002/hep.22506 · Cited by 1,004
The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective
Venook, A. P., Papandreou, C., Furuse, J., & Ladrón de Guevara, L. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-s4-05 · Cited by 965
EMT: When epithelial cells decide to become mesenchymal-like cells
Kalluri, R. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39675 · Cited by 952
Fibroblasts Derive from Hepatocytes in Liver Fibrosis via Epithelial to Mesenchymal Transition
Zeisberg, M., Yang, C., Martino, M., Duncan, M. B., Rieder, F., Tanjore, H., & Kalluri, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700194200 · Cited by 839
MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis
Tsai, W.-C., Hsu, S.-D., Hsu, C.-S., Lai, T.-C., Chen, S.-J., Shen, R., Huang, Y., Chen, H.-C., Lee, C.-H., Tsai, T.-F., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63455 · Cited by 814
Gramantieri, L., Ferracin, M., Fornari, F., Veronese, A., Sabbioni, S., Liu, C.-G., Calin, G. A., Giovannini, C., Ferrazzi, E., Grazi, G. L., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4607 · Cited by 813
WNT Signaling Pathway and Stem Cell Signaling Network
Katoh, M., & Katoh, M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2316 · Cited by 796
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver
Hsu, S.-H., Wang, B., Kota, J., Yu, J., Costinean, S., Kutay, H., Yu, L., Bai, S., La Perle, K., Chivukula, R. R., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63539 · Cited by 774
Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA
Saito, T., Owen, D. M., Jiang, F., Marcotrigiano, J., & Gale, M. (2008) · Nature · doi:10.1038/nature07106 · Cited by 744
Inhibition of the Interferon- Inducible Protein Kinase PKR by HCV E2 Protein
Taylor, D. R., Shi, S. T., Romano, P. R., Barber, G. N., & Lai, M. M. C. (1999) · Science · doi:10.1126/science.285.5424.107 · Cited by 733
EpCAM and α-Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular Carcinoma
Yamashita, T., Forgues, M., Wang, W., Kim, J. W., Ye, Q., Jia, H., Budhu, A., Zanetti, K. A., Chen, Y., Qin, L.-X., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6013 · Cited by 717
Wang, X. W., Forrester, K., Yeh, H., Feitelson, M. A., Gu, J. R., & Harris, C. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2230 · Cited by 665
Self-citationKurrey, N. K., Jalgaonkar, S. P., Joglekar, A. V., Ghanate, A. D., Chaskar, P. D., Doiphode, R. Y., & Bapat, S. A. (2009) · Stem Cells · doi:10.1002/stem.154 · Cited by 655
Transforming Growth Factors β1 and α in Chronic Liver Disease: Effects of Interferon Alfa Therapy
Castilla, A., Prieto, J., & Fausto, N. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104043241401 · Cited by 655
Bolondi, L., Sofia, S., Siringo, S., Gaiani, S., Casali, A., Zironi, G., Piscaglia, F., Gramantieri, L., Zanetti, M., & Sherman, M. (2001) · Gut · doi:10.1136/gut.48.2.251 · Cited by 643
Tumour suppression by p53: a role for the DNA damage response?
Meek, D. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2716 · Cited by 609
Control of cccDNA function in hepatitis B virus infection
Levrero, M., Pollicino, T., Petersen, J., Belloni, L., Raimondo, G., & Dandri, M. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.022 · Cited by 552
Ji, J., Yamashita, T., Budhu, A., Forgues, M., Jia, H., Li, C., Deng, C., Wauthier, E., Reid, L. M., Ye, Q., et al. (2009) · Hepatology · doi:10.1002/hep.22989 · Cited by 532
Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence
Rehermann, B. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39133 · Cited by 531
Wnt/β-Catenin Signaling Regulates Telomerase in Stem Cells and Cancer Cells
Hoffmeyer, K., Raggioli, A., Rudloff, S., Anton, R., Hierholzer, A., Del Valle, I., Hein, K., Vogt, R., & Kemler, R. (2012) · Science · doi:10.1126/science.1218370 · Cited by 526
Interaction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia
Kaidi, A., Williams, A. C., & Paraskeva, C. (2007) · Nature Cell Biology · doi:10.1038/ncb1534 · Cited by 517
The autophagy machinery is required to initiate hepatitis C virus replication
Dreux, M., Gastaminza, P., Wieland, S. F., & Chisari, F. V. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907344106 · Cited by 477
Papatheodoridis, G. V., Lampertico, P., Manolakopoulos, S., & Lok, A. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.02.035 · Cited by 459
Targeted Therapies for Hepatocellular Carcinoma
Villanueva, A., & Llovet, J. M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.03.006 · Cited by 449
Activation of Hepatic Stem Cell Marker EpCAM by Wnt–β-Catenin Signaling in Hepatocellular Carcinoma
Yamashita, T., Budhu, A., Forgues, M., & Wang, X. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0908 · Cited by 446
Toll-Like Receptor Signaling Inhibits Hepatitis B Virus Replication In Vivo
Isogawa, M., Robek, M. D., Furuichi, Y., & Chisari, F. V. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.7269-7272.2005 · Cited by 442
An Oncogenomics-Based In Vivo RNAi Screen Identifies Tumor Suppressors in Liver Cancer
Zender, L., Xue, W., Zuber, J., Semighini, C. P., Krasnitz, A., Ma, B., Zender, P., Kubicka, S., Luk, J. M., Schirmacher, P., et al. (2008) · Cell · doi:10.1016/j.cell.2008.09.061 · Cited by 428
Benn, J., & Schneider, R. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10350 · Cited by 418
Hepatitis B: An important public health issue
Maddrey, W. C. (2000) · Journal of Medical Virology · doi:10.1002/1096-9071(200007)61:3<362::aid-jmv14>3.0.co;2-i · Cited by 390
Ura, S., Honda, M., Yamashita, T., Ueda, T., Takatori, H., Nishino, R., Sunakozaka, H., Sakai, Y., Horimoto, K., & Kaneko, S. (2009) · Hepatology · doi:10.1002/hep.22749 · Cited by 376
Human embryonic genes re-expressed in cancer cells
Monk, M., & Holding, C. (2001) · Oncogene · doi:10.1038/sj.onc.1205088 · Cited by 351
Huang, J., Wang, Y., Guo, Y., & Sun, S. (2010) · Hepatology · doi:10.1002/hep.23660 · Cited by 342
Schiffer, E., Housset, C., Cacheux, W., Wendum, D., Desbois‐Mouthon, C., Rey, C., Clergue, F., Poupon, R., Barbu, V., & Rosmorduc, O. (2005) · Hepatology · doi:10.1002/hep.20538 · Cited by 340
Ke, P.-Y., & Chen, S. S.-L. (2011) · Journal of Clinical Investigation · doi:10.1172/jci41474 · Cited by 336
Polyak, S. J., Khabar, K. S. A., Paschal, D. M., Ezelle, H. J., Duverlie, G., Barber, G. N., Levy, D. E., Mukaida, N., & Gretch, D. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.6095-6106.2001 · Cited by 323
Wu, J., Meng, Z., Jiang, M., Pei, R., Trippler, M., Broering, R., Bucchi, A., Sowa, J.-P., Dittmer, U., Yang, D., et al. (2009) · Hepatology · doi:10.1002/hep.22751 · Cited by 318
Liver extracellular matrix in health and disease
Bedossa, P., & Paradis, V. (2003) · The Journal of Pathology · doi:10.1002/path.1397 · Cited by 308
Regulation of Hepatitis C Virus Translation and Infectious Virus Production by the MicroRNA miR-122
Jangra, R. K., Yi, M., & Lemon, S. M. (2010) · Journal of Virology · doi:10.1128/jvi.00417-10 · Cited by 306
Epithelial–Mesenchymal Transition in Hepatocellular Carcinoma
van Zijl, F., Zulehner, G., Petz, M., Schneller, D., Kornauth, C., Hau, M., Machat, G., Grubinger, M., Huber, H., & Mikulits, W. (2009) · Future Oncology · doi:10.2217/fon.09.91 · Cited by 305
Hepatitis B‐related hepatocellular carcinoma: epidemiological characteristics and disease burden
Nguyen, V. T. T., Law, M. G., & Dore, G. J. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01117.x · Cited by 302
Subversion of Cellular Autophagy Machinery by Hepatitis B Virus for Viral Envelopment
Li, J., Liu, Y., Wang, Z., Liu, K., Wang, Y., Liu, J., Ding, H., & Yuan, Z. (2011) · Journal of Virology · doi:10.1128/jvi.02627-10 · Cited by 293
Hepatocellular Carcinoma: Molecular Pathways and New Therapeutic Targets
Roberts, L. R., & Gores, G. J. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-871200 · Cited by 289
Chung, T., Lee, Y., & Kim, C. (2004) · The FASEB Journal · doi:10.1096/fj.03-1429fje · Cited by 288
Expression of Hepatitis C Virus Proteins Inhibits Signal Transduction through the Jak-STAT Pathway
Heim, M. H., Moradpour, D., & Blum, H. E. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8469-8475.1999 · Cited by 287
Embryonic stem cell markers expression in cancers
Schoenhals, M., Kassambara, A., Vos, J. D., Hose, D., Moreaux, J., & Klein, B. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.156 · Cited by 265
van der Molen, R. G., Sprengers, D., Binda, R. S., de Jong, E. C., Niesters, H. G. M., Kusters, J. G., Kwekkeboom, J., & Janssen, H. L. A. (2004) · Hepatology · doi:10.1002/hep.20366 · Cited by 257
Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition
Guarino, M., Tosoni, A., & Nebuloni, M. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.02.020 · Cited by 253
TGF-β-induced epithelial to mesenchymal transition
Jian, J. I. A. N., Xü, Samy, Lamouille, Rik, & Derynck (2009) · Cell Research · Cited by 252
Su, F., & Schneider, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4558-4566.1996 · Cited by 229
Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis
Feitelson, M. A., & Lee, J. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.11.010 · Cited by 228
Self-citationBim-mediated deletion of antigen-specific CD8+ T cells in patients unable to control HBV infection
Lopes, A. R., Kellam, P., Das, A., Dunn, C., Kwan, A., Turner, J., Peppa, D., Gilson, R. J., Gehring, A., Bertoletti, A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33402 · Cited by 218
Tanabe, K. K., Lemoine, A., Finkelstein, D. M., Kawasaki, H., Fujii, T., Chung, R. T., Lauwers, G. Y., Kulu, Y., Muzikansky, A., Kuruppu, D., et al. (2008) · JAMA · doi:10.1001/jama.2007.65 · Cited by 207
Marquardt, J. U., Galle, P. R., & Teufel, A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.07.007 · Cited by 195
Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia‐inducible factor‐1α
Moon, E., Jeong, C., Jeong, J., Rok Kim, K., Yu, D., Murakami, S., Woo Kim, C., & Kim, K. (2004) · The FASEB Journal · doi:10.1096/fj.03-0153fje · Cited by 187
Ageing, telomeres, senescence, and liver injury
Hoare, M., Das, T., & Alexander, G. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.009 · Cited by 181
Blivet-Van Eggelpoël, M.-J., Chettouh, H., Fartoux, L., Aoudjehane, L., Barbu, V., Rey, C., Priam, S., Housset, C., Rosmorduc, O., & Desbois-Mouthon, C. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.019 · Cited by 181
Yoo, Y.-G., Oh, S. H., Park, E. S., Cho, H., Lee, N., Park, H., Kim, D. K., Yu, D.-Y., Seong, J. K., & Lee, M.-O. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305101200 · Cited by 177
Diao, J., Pantua, H., Ngu, H., Kömüves, L. G., Diehl, L. J., Schaefer, G., & Kapadia, S. B. (2012) · Journal of Virology · doi:10.1128/jvi.00750-12 · Cited by 172
Ripoli, M., D'Aprile, A., Quarato, G., Sarasin-Filipowicz, M., Gouttenoire, J., Scrima, R., Cela, O., Boffoli, D., Heim, M. H., Moradpour, D., et al. (2010) · Journal of Virology · doi:10.1128/jvi.00769-09 · Cited by 172
Hepatocellualar Carcinoma Serum Markers
Bertino, G., Ardiri, A., Malaguarnera, M., Malaguarnera, G., Bertino, N., & Calvagno, G. S. (2012) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.05.001 · Cited by 167
Copple, B. L. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02205.x · Cited by 164
Hepatitis B virus X gene and hepatocarcinogenesis
Ng, S., & Lee, C. G. L. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0415-9 · Cited by 164
Zhang, Z., Zhang, S., Zou, Z., Shi, J., Zhao, J., Fan, R., Qin, E., Li, B., Li, Z., Xu, X., et al. (2010) · Hepatology · doi:10.1002/hep.23977 · Cited by 164
Novel therapeutic Strategies for Targeting Liver Cancer Stem Cells
Oishi, N., & Wang, X. W. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.517 · Cited by 161
Wu, C., Tsai, Y., Wu, M.-Z., Teng, S., & Wu, K. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.05.005 · Cited by 156
Wang, Z. (2012) · Oncology Reports · doi:10.3892/or.2012.1682 · Cited by 154
Hypoxia and Hypoxia Inducible Factors in Cancer Stem Cell Maintenance
Li, Z., & Rich, J. N. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_75 · Cited by 153
Yang, Y., Zhao, W., Zhong, Y. ‐., Xia, H., Shen, L., & Zhang, N. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01070.x · Cited by 146
Lee, D. K., Park, S. H., Yi, Y., Choi, S.-G., Lee, C., Parks, W. T., Cho, H., de Caestecker, M. P., Shaul, Y., Roberts, A. B., et al. (2001) · Genes & Development · doi:10.1101/gad.856201 · Cited by 143
Dayyeh, B. K. A., YANG, M. H., Fuchs, B. C., Karl, D. L., Yamada, S., Sninsky, J. J., OʼBrien, T. R., Dienstag, J. L., Tanabe, K. K., & Chung, R. T. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.03.045 · Cited by 141
Battaglia, S., Benzoubir, N., Nobilet, S., Charneau, P., Samuel, D., Zignego, A. L., Atfi, A., Bréchot, C., & Bourgeade, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004355 · Cited by 138
Lu, T., Lu, R., Liao, M., Yu, J., Chung, C.-H., Kao, C.-F., & Wu, H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.077081 · Cited by 138
Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options
Gressner, O. A., Weiskirchen, R., & Gressner, A. M. (2007) · Comparative Hepatology · doi:10.1186/1476-5926-6-7 · Cited by 137
Kao, C.-F., Chen, S.-Y., Chen, J., & Lee, Y. W. (2004) · Oncogene · doi:10.1038/sj.onc.1207368 · Cited by 136
Biomarkers for Hepatocellular Carcinoma
Behne, T., & Copur, M. S. (2012) · International Journal of Hepatology · doi:10.1155/2012/859076 · Cited by 132
Bouchard, M. J., Puro, R. J., Wang, L., & Schneider, R. J. (2003) · Journal of Virology · doi:10.1128/jvi.77.14.7713-7719.2003 · Cited by 131
Liu, J., Ding, X., Tang, J., Cao, Y., Hu, P., Zhou, F., Shan, X., Cai, X.-F., Chen, Q., Ling, N., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027496 · Cited by 127
Emerging Epigenetic Targets and Therapies in Cancer Medicine
Popovic, R., & Licht, J. D. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0076 · Cited by 126
Clippinger, A. J., & Bouchard, M. J. (2008) · Journal of Virology · doi:10.1128/jvi.00154-08 · Cited by 126
Does the Hepatitis B Antigen HBx Promote the Appearance of Liver Cancer Stem Cells?
Arzumanyan, A. L., Friedman, T., Ng, I. O., Clayton, M. M., Lian, Z., & Feitelson, M. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3951 · Cited by 121
Self-citationMerquiol, E., Uzi, D., Mueller, T., Goldenberg, D., Nahmias, Y., Xavier, R. J., Tirosh, B., & Shibolet, O. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024660 · Cited by 116
HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-β1
Shin, J. Y., Hur, W., Wang, J. S., Jang, J. W., Kim, C. W., Bae, S. H., Jang, S. K., Yang, S. H., Sung, Y. C., Kwon, O. J., et al. (2005) · Experimental & Molecular Medicine · doi:10.1038/emm.2005.19 · Cited by 115
Epigenetic repression of E-cadherin expression by hepatitis B virus x antigen in liver cancer
Arzumanyan, A. L., Friedman, T., Kotei, E., Ng, I. O., Lian, Z., & Feitelson, M. A. (2011) · Oncogene · doi:10.1038/onc.2011.255 · Cited by 114
Self-citationHepatitis C Virus Population Dynamics During Infection
Pawlotsky, J. (2006) · Current topics in microbiology and immunology · doi:10.1007/3-540-26397-7_9 · Cited by 110
Zhao, J., Wu, G., Bu, F., Lü, B., Liang, A., Cao, L., Tong, X., Lü, X., Wu, M., & Guo, Y. (2009) · Hepatology · doi:10.1002/hep.23247 · Cited by 109
Machida, K., McNamara, G. T., Cheng, K. T.-H., Huang, J. Y., Wang, C., Comai, L., Ou, J. J., & Lai, M. M. C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000618 · Cited by 107
Tomuleasa, C., Şoriţău, O., Rus-Ciuca, D., Pop, T., Todea, D., Moșteanu, O., Pintea, B., Foris, V., Șușman, S., Kacsó, G., et al. (2010) · PubMed · Cited by 100
Hepatitis B vaccination in children: The Taiwan experience
Ni, Y., & Chen, D. (2010) · Pathologie Biologie · doi:10.1016/j.patbio.2009.11.002 · Cited by 100
Yang, B., & Bouchard, M. J. (2011) · Journal of Virology · doi:10.1128/jvi.06442-11 · Cited by 98
Tarn, C., Lee, S., Hu, Y., Ashendel, C. L., & ANDRISANI, O. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104105200 · Cited by 97
Yang, F., Yan, S., He, Y., Wang, F., Song, S., Guo, Y., Zhou, Q., Wang, Y., Lin, Z., Yang, Y., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.06.021 · Cited by 96
Ali, N., Allam, H., May, R. J., Sureban, S. M., Bronze, M. S., Bader, T. F., Umar, S., ANANT, S., & Houchen, C. W. (2011) · Journal of Virology · doi:10.1128/jvi.05920-11 · Cited by 94
Cho, H. K., Cheong, K. J., Kim, H. Y., & Cheong, J. (2011) · Biochemical Journal · doi:10.1042/bj20102071 · Cited by 94
Molecular Profiling of Hepatocellular Carcinomas (HCC) Using a Large-Scale Real-Time RT-PCR Approach
Paradis, V., Bièche, I., Dargère, D., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63700-5 · Cited by 89
The hepatitis B virus HBx protein induces adherens junction disruption in a src-dependent manner
Lara‐Pezzi, E., Roche, S., ANDRISANI, O. M., Sánchez‐Madrid, F., & López‐Cabrera, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204451 · Cited by 87
Hepatitis B Virus Promotes Angiopoietin-2 Expression in Liver Tissue
Sanz-Cameno, P., Martín‐Vílchez, S., Lara‐Pezzi, E., Borque, M. J., Salmerón, J., de Rueda, P. M., Solís, J. A., López‐Cabrera, M., & Moreno‐Otero, R. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051246 · Cited by 81
Akkari, L., Grégoire, D., Floc’h, N., Moreau, M., Hernandez, C., Simonin, Y., Rosenberg, A. R., Lassus, P., & Hibner, U. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.06.027 · Cited by 80
Trans-Activation of Epidermal Growth Factor Receptor Gene by the Hepatitis B Virus X-Gene Product
Menzo, S., Clementi, M., Alfani, E., Bagnarelli, P., Iacovacci, S., Manzin, A., Dandri, M., Natoli, G., Levrero, M., & Carloni, G. (1993) · Virology · doi:10.1006/viro.1993.1550 · Cited by 74
Ming-Ju, H., Hsieh, Y., Tzy‐Yen, C., & Hui‐Ling, C. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22926 · Cited by 67
Epigenetic Drivers of Genetic Alterations
Toyota, M., & Suzuki, H. (2010) · Advances in genetics · doi:10.1016/b978-0-12-380866-0.60011-3 · Cited by 66
Mechanism of the interferon alpha response against hepatitis C virus replicons
Guo, J., Sohn, J. A., Zhu, Q., & Seeger, C. (2004) · Virology · doi:10.1016/j.virol.2004.04.031 · Cited by 66
Feitelson, M. A. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.07.009 · Cited by 66
Self-citationAkbar, S., INABA, K., & Onji, M. (1996) · Immunology · doi:10.1046/j.1365-2567.1996.516576.x · Cited by 65
Benegiamo, G., Vinciguerra, M., Mazzoccoli, G., Piepoli, A., Andriulli, A., & Pazienza, V. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2160-1 · Cited by 65
Hypermethylated levels of E-cadherin promoter in Huh-7 cells expressing the HCV core protein
Ripoli, M. C., Barbano, R., Balsamo, T., Piccoli, C., Brunetti, V., Coco, M., Mazzoccoli, G., Vinciguerra, M., & Pazienza, V. (2011) · Virus Research · doi:10.1016/j.virusres.2011.05.014 · Cited by 65
Jin, Y. M., Yun, C., Park, C., Wang, H., & Cho, H. (2001) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2001.00308.x · Cited by 65
Fujinaga, H., Tsutsumi, T., Yotsuyanagi, H., Moriya, K., & Koike, K. (2011) · Oncology · doi:10.1159/000333253 · Cited by 61
Okamoto, K., Ishida, C., Ikebuchi, Y., Mandai, M., Mimura, K., Murawaki, Y., & Yuasa, I. (2010) · Internal Medicine · doi:10.2169/internalmedicine.49.3268 · Cited by 61
Lim, J. S., Park, S., & Jang, K. L. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.01.044 · Cited by 58
Biology of hepatic cancer stem cells
Tong, C. M., Ma, S., & Guan, X. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06762.x · Cited by 56
Shih, W., Kuo, M., Chuang, S., Cheng, A., & Doong, S.-L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302580200 · Cited by 56
Risk of hepatocellular carcinoma in hepatitis B and prevention through treatment
Carey, W. D., & Sherman, M. (2009) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.76.s3.02 · Cited by 53
Park, S., Jung, J. K., Lim, J. S., Tiwari, I., & Jang, K. L. (2011) · Journal of General Virology · doi:10.1099/vir.0.029512-0 · Cited by 49
Sedlaczek, N., Hasilík, A., Neuhaus, P., Schuppan, D., & Herbst, H. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600777 · Cited by 48
HBx protein induces EMT through c-Src activation in SMMC-7721 hepatoma cell line
Yang, S. Z., Zhang, L. D., Zhang, Y., Xiong, Y., Zhang, Y., Li, H. L., Li, X. W., & Jia, D. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.079 · Cited by 48
Abe, M., Koga, H., Yoshida, T., Masuda, H., Iwamoto, H., Sakata, M., Hanada, S., Nakamura, T., Taniguchi, E., Kawaguchi, T., et al. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00953.x · Cited by 47
Grant, T. J., Bishop, J. A., Christadore, L. M., Barot, G., Chin, H. G., Woodson, S., Kavouris, J. A., Siddiq, A., Gredler, R., Shen, X., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121601109 · Cited by 47
Liu, J., Ahiekpor, A., Li, L., Li, X., Arbuthnot, P. B., Kew, M. C., & Feitelson, M. A. (2009) · International Journal of Cancer · doi:10.1002/ijc.24580 · Cited by 43
Self-citationZhao, R. C., Zhu, Y., & Shi, Y. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.04.008 · Cited by 43
Bhargava, A., Raghuram, G. V., Pathak, N., Varshney, S., Jatawa, S. K., Jain, D., & Mishra, P. K. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.08.009 · Cited by 42
Lin, L., Verslype, C., van Pelt, J. F., Ranst, M. A. V., & Fevery, J. (2006) · European Journal of Gastroenterology & Hepatology · doi:10.1097/01.meg.0000243881.09820.09 · Cited by 41
Molecular targeted therapy for hepatocellular carcinoma in the current and potential next strategies
Tanaka, S., & Arii, S. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0387-9 · Cited by 40
Anders, R. A., Yerian, L. M., Tretiakova, M., Davison, J. M., Quigg, R. J., Domer, P. H., Hoberg, J. E., & Hart, J. A. L. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63893-x · Cited by 40
Hepatitis B virus X protein overcomes oncogenic RAS‐induced senescence in human immortalized cells
Oishi, N., Shilagardi, K., Nakamoto, Y., Honda, M., Kaneko, S., & Murakami, S. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00579.x · Cited by 37
Chung, Y. (2011) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2011.699 · Cited by 37
Liu, T., Fang, Y., Xiong, H., Chen, T., Ni, Z., Luo, J., Zhao, N., & Shen, X. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3059 · Cited by 34
Microarray-Based Gene Expression Analysis of Hepatocellular Carcinoma
Maass, T., Sfakianakis, I., Staib, F., Krupp, M., Galle, P. R., & Teufel, A. (2010) · Current Genomics · doi:10.2174/138920210791233063 · Cited by 33
Angiogenic Activity of Hepatitis B and C Viruses
Vrancken, K., Paeshuyse, J., & Liekens, S. (2011) · Antiviral chemistry & chemotherapy · doi:10.3851/imp1987 · Cited by 33
Pfannkuche, A., Büther, K., Karthe, J., Poenisch, M., Bartenschlager, R. F. W., Trilling, M., Hengel, H., Willbold, D., Häussinger, D., & Bode, J. G. (2011) · Hepatology · doi:10.1002/hep.24214 · Cited by 33
Targeting mitochondria in the infection strategy of the hepatitis C virus
Quarato, G., Scrima, R., Agriesti, F., Moradpour, D., Capitanio, N., & Piccoli, C. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.06.008 · Cited by 27
Niu, D., Feng, H., & Chen, W. N. (2010) · Journal of Proteomics · doi:10.1016/j.jprot.2010.02.016 · Cited by 26
Vandermeeren, A. M., Gómez, C. E., Patiño, C., Domingo-Gil, E., Guerra, S., González, J. M., & Estéban, M. (2008) · Virology Journal · doi:10.1186/1743-422x-5-102 · Cited by 13
[Regulation of microRNA-122 on HBV replication by targeting HBx sequence].
Hao, M., Zheng, S.-J., Ding, H., & Huang, A. (2011) · PubMed · Cited by 6
Cited by
Identification of genomic alterations in oesophageal squamous cell cancer
Song, Y., Li, L., Ou, Y., Gao, Z., Li, E., Li, X., Zhang, W., Wang, J., Xu, L., Zhou, Y., et al. (2014) · Nature · doi:10.1038/nature13176 · Cited by 1,083
Immunity, inflammation and cancer: a leading role for adenosine
Antonioli, L., Blandizzi, C., Pacher, P., & Haskó, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3613 · Cited by 765
Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance
Luedde, T., Kaplowitz, N., & Schwabe, R. F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.018 · Cited by 759
Human Viral Oncogenesis: A Cancer Hallmarks Analysis
Mesri, E. A., Feitelson, M. A., & Munger, K. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.011 · Cited by 650
Self-citationPapatheodoridis, G. V., Chan, H. L.-Y., Hansen, B. E., Janssen, H. L. A., & Lampertico, P. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.01.002 · Cited by 511
Metadata
- Authors
- Arzumanyan, A., Reis, H. M. G. P. V., & Feitelson, M. A.
- Venue
- Nature Reviews Cancer
- Published
- 2013-01-24
- Volume
- 13
- Issue
- 2
- Pages
- 123-135
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1982154889
- Cited by
- 800
- References
- 160
- FWCI
- 13.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.